Acute hyperglycemia reduces myocardial blood flow reserve and the magnitude of reduction is associated with insulin resistance: A study in nondiabetic humans using contrast echocardiography

Heart and Vessels

Volumn 28, Issue 6, 2013, Pages 757-768

  Abdelmoneim, Sahar S ^a,b   Hagen, Mary E ^a   Mendrick, Edward ^a   Pattan, Vishwanath ^a   Wong, Benjamin ^a   Norby, Barbara ^a   Roberson, Tamara ^a   Szydel, Troy ^a   Basu, Rita ^a   Basu, Ananda ^a   Mulvagh, Sharon L ^a  

^a MAYO CLINIC   (United States)

^b ASSIUT UNIVERSITY   (Egypt)

Author keywords

Insulin resistance; Myocardial blood flow reserve; Myocardial perfusion contrast echocardiography

Indexed keywords

GLUCAGON; GLUCOSE; GROWTH HORMONE; INSULIN; REGADENOSON; SOMATOSTATIN;

ADULT; ARTICLE; CONCENTRATION RESPONSE; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HEART MUSCLE BLOOD FLOW; HUMAN; HUMAN EXPERIMENT; HYPERGLYCEMIA; INSULIN RESISTANCE; MALE; MIDDLE AGED; MYOCARDIAL BLOOD FLOW RESERVE; NON INVASIVE PROCEDURE; NORMAL HUMAN; PRIORITY JOURNAL; STEADY STATE;

ACUTE DISEASE; ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CONTRAST MEDIA; CORONARY CIRCULATION; ECHOCARDIOGRAPHY; FEMALE; FLUOROCARBONS; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERGLYCEMIA; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; PURINES; PYRAZOLES; REPRODUCIBILITY OF RESULTS; TIME FACTORS; VASODILATOR AGENTS;

EID: 84890117171     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-012-0305-y     Document Type: Article

References (42)

1. Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, Krumholz HM (2005) Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 111:3078-3086
2. Williams SB, Goldfine AB, Timimi FK, Ting HH, Roddy MA, Simonson DC, Creager MA (1998) Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 97:1695-1701
3. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA (1993) Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 88:2510-2516
4. Giugliano D, Marfella R, Coppola L, Verrazzo G, Acampora R, Giunta R, Nappo F, Lucarelli C, D'Onofrio F (1997) Vascular effects of acute hyperglycemia in humans are reversed by l-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia. Circulation 95:1783-1790
5. Wei K, Crouse L, Weiss J, Villanueva F, Schiller NB, Naqvi TZ, Siegel R, Monaghan M, Goldman J, Aggarwal P, Feigenbaum H, DeMaria A (2003) Comparison of usefulness of dipyridamole stress myocardial contrast echocardiography to technetium-99m sestamibi single-photon emission computed tomography for detection of coronary artery disease (pb127 multicenter phase 2 trial results). Am J Cardiol 91:1293-1298
6. Cosyns B, Droogmans S, Hernot S, Degaillier C, Garbar C, Weytjens C, Roosens B, Schoors D, Lahoutte T, Franken PR, Van Camp G (2008) Effect of streptozotocin-induced diabetes on myocardial blood flow reserve assessed by myocardial contrast echocardiography in rats. Cardiovasc Diabetol 7:26
7. Hansen A, Johansson BL, Wahren J, von Bibra H (2002) C-peptide exerts beneficial effects on myocardial blood flow and function in patients with type 1 diabetes. Diabetes 51:3077-3082
8. Moir S, Hanekom L, Fang ZY, Haluska B, Wong C, Burgess M, Marwick TH (2006) Relationship between myocardial perfusion and dysfunction in diabetic cardiomyopathy: a study of quantitative contrast echocardiography and strain rate imaging. Heart 92:1414-1419
9. Basu A, Basu R, Shah P, Vella A, Johnson CM, Jensen M, Nair KS, Schwenk WF, Rizza RA (2001) Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity. Diabetes 50:1351-1362
10. Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S (1998) Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 97:473-483
11. Abdelmoneim SS, Basu A, Bernier M, Dhoble A, Abdel-Kader SS, Pellikka PA, Mulvagh SL (2011) Detection of myocardial microvascular disease using contrast echocardiography during adenosine stress in type 2 diabetes mellitus: prospective comparison with single-photon emission computed tomography. Diab Vasc Dis Res 8:254-261
12. Porter TR, Adolphson M, High RR, Smith LM, Olson J, Erdkamp M, Xie F, O'Leary E, Wong BF, Eifert-Rain S, Hagen ME, Abdelmoneim SS, Mulvagh SL (2011) Rapid detection of coronary artery stenoses with real-time perfusion echocardiography during regadenoson stress. Circ Cardiovasc Imaging 4:628-635
13. Abdelmoneim SS, Bernier M, Scott CG, Dhoble A, Ness SA, Hagen ME, Moir S, McCully RB, Pellikka PA, Mulvagh SL (2009) Safety of contrast agent use during stress echocardiography: a 4-year experience from a single-center cohort study of 26,774 patients. JACC Cardiovasc Imaging 2:1048-1056
14. Vogel R, Indermuhle A, Reinhardt J, Meier P, Siegrist PT, Namdar M, Kaufmann PA, Seiler C (2005) The quantification of absolute myocardial perfusion in humans by contrast echocardiography: algorithm and validation. J Am Coll Cardiol 45:754-762
15. Vogel R, Indermuhle A, Seiler C (2007) Determination of the absolute perfusion threshold preventing myocardial ischaemia in humans. Heart 93:115-116
16. Cerqueira MD (2006) Advances in pharmacologic agents in imaging: new a2a receptor agonists. Curr Cardiol Rep 8:119-122
17. Kanatsuka H, Lamping KG, Eastham CL, Marcus ML (1990) Heterogeneous changes in epimyocardial microvascular size during graded coronary stenosis. Evidence of the microvascular site for autoregulation. Circ Res 66:389-396
18. Hage FG, Perry G, Heo J, Iskandrian AE (2010) Blunting of the heart rate response to adenosine and regadenoson in relation to hyperglycemia and the metabolic syndrome. Am J Cardiol 105:839-843
19. Kaul S (2001) The role of capillaries in determining coronary blood flow reserve: implications for stress-induced reversible perfusion defects. J Nucl Cardiol 8:694-700
20. Nahser PJ Jr, Brown RE, Oskarsson H, Winniford MD, Rossen JD (1995) Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation 91:635-640
21. Schindler TH, Zhang XL, Vincenti G, Mhiri L, Lerch R, Schelbert HR (2007) Role of PET in the evaluation and understanding of coronary physiology. J Nucl Cardiol 14:589-603
22. Garnock-Jones KP, Curran MP (2010) Regadenoson. Am J Cardiovasc Drugs 10:65-71
23. Fujimoto K, Hozumi T, Watanabe H, Tokai K, Shimada K, Yoshiyama M, Homma S, Yoshikawa J (2006) Acute hyperglycemia induced by oral glucose loading suppresses coronary microcirculation on transthoracic Doppler echocardiography in healthy young adults. Echocardiography 23:829-834
24. Ceriello A, Quagliaro L, D'Amico M, Di Filippo C, Marfella R, Nappo F, Berrino L, Rossi F, Giugliano D (2002) Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes 51:1076-1082
25. Fujii N, Tsuchihashi K, Sasao H, Eguchi M, Miurakami H, Hase M, Higashiura K, Yuda S, Hashimoto A, Miura T, Ura N, Shimamoto K (2008) Insulin resistance functionally limits endothelium-dependent coronary vasodilation in nondiabetic patients. Heart Vessels 23:9-15
26. Oyama N, Urasawa K, Sakai H, Fujii S, Kitabatake A (2005) Insulin resistance relates to acetylcholine-induced microvascular vasoconstriction in a patient with vasospastic angina: potential implication of causalities between hyperinsulinemia and coronary microcirculation failure. Heart Vessels 20:72-76
27. DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223
28. Harano Y, Hidaka H, Takatsuki K, Ohgaku S, Haneda M, Motoi S, Kawagoe K, Shigeta Y, Abe H (1978) Glucose, insulin, and somatostatin infusion for the determination of insulin sensitivity in vivo. Metabolism 27:1449-1452
29. Cheung JY, Conover C, Regen DM, Whitfield CF, Morgan HE (1978) Effect of insulin on kinetics of sugar transport in heart muscle. Am J Physiol 234:E70-E78
30. Laight DW, Carrier MJ, Anggard EE (2000) Antioxidants, diabetes and endothelial dysfunction. Cardiovasc Res 47:457-464
31. Neri S, Calvagno S, Mauceri B, Misseri M, Tsami A, Vecchio C, Mastrosimone G, Di Pino A, Maiorca D, Judica A, Romano G, Rizzotto A, Signorelli SS (2010) Effects of antioxidants on postprandial oxidative stress and endothelial dysfunction in subjects with impaired glucose tolerance and type 2 diabetes. Eur J Nutr 49:409-416
32. Digerness SB, Harris KD, Kirklin JW, Urthaler F, Viera L, Beckman JS, Darley-Usmar V (1999) Peroxynitrite irreversibly decreases diastolic and systolic function in cardiac muscle. Free Radic Biol Med 27:1386-1392
33. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H, Nawata H (2000) High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49:1939-1945
34. Fredholm BB, IJ AP, Jacobson KA, Klotz KN, Linden J (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527-552
35. 2+ uptake. Cell Biochem Funct 26:833-843
36. Maeda T, Koos BJ (2009) Adenosine A1 and A2A receptors modulate insulinemia, glycemia, and lactatemia in fetal sheep. Am J Physiol Regul Integr Comp Physiol 296:R693-R701
37. Palani G, Ananthasubramaniam K (2012) Regadenoson: review of its established role in myocardial perfusion imaging and emerging applications. Cardiol Rev [Epub ahead of print]
38. Gordi T, Frohna P, Sun HL, Wolff A, Belardinelli L, Lieu H (2006) A population pharmacokinetic/pharmacodynamic analysis of regadenoson, an adenosine A2A-receptor agonist, in healthy male volunteers. Clin Pharmacokinet 45:1201-1212
39. Lafitte S, Masugata H, Peters B, Togni M, Strachan M, Yao B, Kwan OL, DeMaria AN (2001) Accuracy and reproducibility of coronary flow rate assessment by real-time contrast echocardiography: in vitro and in vivo studies. J Am Soc Echocardiog 14:1010-1019
40. Abdelmoneim SS, Dhoble A, Bernier M, Erwin PJ, Korosoglou G, Senior R, Moir S, Kowatsch I, Xian-Hong S, Muro T, Dawson D, Vogel R, Wei K, West CP, Montori VM, Pellikka PA, Abdel-Kader SS, Mulvagh SL (2009) Quantitative myocardial contrast echocardiography during pharmacological stress for diagnosis of coronary artery disease: a systematic review and meta-analysis of diagnostic accuracy studies. Eur J Echocardiogr 10:813-825
41. Capes SE, Hunt D, Malmberg K, Gerstein HC (2000) Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355:773-778
42. Mineoka Y, Fukui M, Tanaka M, Tomiyasu K, Akabame S, Nakano K, Yamazaki M, Hasegawa G, Oda Y, Nakamura N (2012) Relationship between cardio-ankle vascular index (CAVI) and coronary artery calcification (CAC) in patients with type 2 diabetes mellitus. Heart Vessels 27(2):160-165